Literature DB >> 21815153

Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.

Li Xiong1, Zhulin Yang, Leping Yang, Jieqiong Liu, Xiongying Miao.   

Abstract

OBJECTIVE: This article is intended to make a study on the expressive levels of mucin core proteins (MUC1 and MUC5AC) and detect their clinicopathologic significances in the benign and malignant lesions of gallbladder.
METHODS: EnVision immunohistochemical method for determining the expressions of MUC1 and MUC5AC was used in routinely paraffin-embedded sections of surgically resected specimens from gallbladder adenocarcinoma (n = 108), peritumoral tissues (n = 46), adenoma (n = 15), and chronic cholecystitis (n = 35).
RESULTS: The positive rate of MUC1 expression was significantly higher in gallbladder adenocarcinoma than that in peritumoral tissues (χ(2)  = 16.49, P < 0.01), adenoma (χ(2)  = 7.40, P < 0.01), and chronic cholecystitis (χ(2)  = 28.57, P < 0.01), while the positive rate of MUC5AC expression was significantly lower in gallbladder adenocarcinoma than that in peritumoral tissues (χ(2)  = 12.83, P < 0.01), adenoma (χ(2)  = 4.22, P < 0.05), and chronic cholecystitis (χ(2)  = 20.25, P < 0.01). The positive cases of MUC1 and the negative ones of MUC5AC in the benign lesions showed moderate- or severe-dysplasia of gallbladder epithelium. The positive rates of MUC1 were significantly lower in gallbladder adenocarcinomas with maximal diameter of mass <2 cm, no metastasis of lymph node, and no invasiveness of regional tissues (P < 0.05 or P < 0.01) than those in gallbladder adenocarcinomas with maximal diameter of mass >2 cm, metastasis of lymph node, and invasiveness of regional tissues (P < 0.05 or P < 0.01). However, the positive rates of MUC5AC were significantly higher in the highly differentiated adenocarcinoma with maximal diameter of mass <2 cm than those in the low-differentiated adenocarcinoma with maximal diameter of mass ≥2 cm. Univariate Kaplan-Meier analysis showed that increased expression of MUC1 (P = 0.064) or decreased expression of MUC5AC (P = 0.017) was associated with decreased overall survival. Multivariate Cox regression analysis showed that decreased expression of MUC5AC (P = 0.008) was an independent prognostic predictor to gallbladder adenocarcinoma.
CONCLUSIONS: The expression of MUC1 and MUC5AC might be closely related to the carcinogenesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815153     DOI: 10.1002/jso.22055

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Immunohistochemical Study of MUC1 and MUC5AC Expression in Gall Bladder Lesions.

Authors:  Amit Bhoge; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Bageshri Gogate; Maithili Mandar Kulkarni; Pallavi Bhayekar
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 2.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

3.  Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.

Authors:  Hou-Shan Yao; Chang Sun; Xin-Xing Li; Yi Wang; Kai-Zhou Jin; Xiao-Ping Zhang; Zhi-Qian Hu
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

4.  Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report.

Authors:  Makoto Kawamoto; Yoshiyuki Wada; Norihiro Koya; Yuko Takami; Hideki Saitsu; Naoki Ishizaki; Mineo Tabata; Hideya Onishi; Masafumi Nakamura; Takashi Morisaki
Journal:  Surg Case Rep       Date:  2018-09-15

Review 5.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

6.  High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.

Authors:  Hiroshi Kono; Masafumi Nakamura; Takao Ohtsuka; Yosuke Nagayoshi; Yasuhisa Mori; Shunichi Takahata; Shinichi Aishima; Masao Tanaka
Journal:  Oncol Rep       Date:  2013-05-09       Impact factor: 3.906

7.  Expression of MUC1 and MUC4 in gallbladder adenocarcinoma.

Authors:  Su-Mi Kim; Sun-Ju Oh; Bang Hur
Journal:  Korean J Pathol       Date:  2012-10-25

8.  KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.

Authors:  Xuyang Hou; Qiuguo Li; Leping Yang; Zhulin Yang; Jun He; Qinglong Li; Daming Li
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-25

Review 9.  MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.

Authors:  Yixin Yang; Christopher Alderman; Ayoub Sehlaoui; Yuan Xiao; Wei Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26

10.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.